Harbour Investments’s HUMANIGEN, INC. HGEN Stock Holding History

Harbour Investments’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-75	Closed	-$11	–	3151
2023 Q2	$11	Hold	75	–	–	﹤0.01%	3011
2023 Q1	$11	Hold	75	–	–	﹤0.01%	2982
2022 Q4	$9	Hold	75	–	–	﹤0.01%	2983
2022 Q3	$0	Hold	75	–	–	﹤0.01%	2879
2022 Q2	$0	Buy	+75	New	+$168	﹤0.01%	2879
2021 Q4	$0	Hold	75	–	–	﹤0.01%	3894
2021 Q3	$0	Hold	75	–	–	﹤0.01%	4085
2021 Q2	$1K	Hold	75	–	–	﹤0.01%	3703
2021 Q1	$1K	Buy	+75	New	+$1.37K	﹤0.01%	3533

Other funds holding HGEN

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

DWP

Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Harbour Investments's HGEN Position: Q3 2023 in Review

Harbour Investments sold out of HUMANIGEN, INC. (HGEN) in Q3 2023, closing a stake of 75 shares — an estimated $11 sold.

Harbour Investments first reported a position in HGEN in Q1 2021 and held it in 9 quarters. The position peaked at $1K in Q2 2021. 3 funds tracked by Wall St. Rank hold HGEN as of Q3 2023.

Harbour Investments reported no remaining HUMANIGEN, INC. position as of Q3 2023 after selling out during the quarter.
Harbour Investments sold 75 HUMANIGEN, INC. shares in Q3 2023, an estimated $11.
Harbour Investments first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 9 quarters.
Harbour Investments's HUMANIGEN, INC. position peaked at $1K in Q2 2021.
3 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q3 2023.

Based on Harbour Investments's 13F filing for Q3 2023, filed 15 Nov 2023.